Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 75.05%674.53M | ---- | 21.69%385.35M | ---- | -30.65%316.67M | ---- | 57.47%456.62M | ---- | -13.87%289.97M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 19.16%-12.52M | ---- | 3.42%-15.49M | ---- | 26.60%-16.04M | ---- | -165.23%-21.85M | ---- | -17.75%-8.24M |
| Attributable subsidiary (profit) loss | ---- | -61.53%-4.01M | ---- | 2.13%-2.49M | ---- | 35.00%-2.54M | ---- | -96.97%-3.91M | ---- | 29.33%-1.98M |
| Impairment and provisions: | ---- | 122.76%23.62M | ---- | -72.64%10.6M | ---- | -17.75%38.76M | ---- | 54.13%47.12M | ---- | 1,204.18%30.57M |
| -Impairmen of inventory (reversal) | ---- | 127.69%20.7M | ---- | -78.05%9.09M | ---- | 17.85%41.43M | ---- | 44.73%35.15M | ---- | --24.29M |
| -Impairment of trade receivables (reversal) | ---- | 93.12%2.92M | ---- | 156.63%1.51M | ---- | -122.31%-2.67M | ---- | --11.97M | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --6.28M |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | -252.26%-1.09M | ---- | -30,900.00%-310K | ---- | 99.94%-1K |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | ---- | -252.26%-1.09M | ---- | -30,900.00%-310K | ---- | 99.94%-1K |
| Asset sale loss (gain): | ---- | 11.24%1.68M | ---- | 254.33%1.51M | ---- | 216.30%427K | ---- | 287.50%135K | ---- | -71.43%-72K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 11.24%1.68M | ---- | 254.33%1.51M | ---- | 216.30%427K | ---- | 287.50%135K | ---- | -71.43%-72K |
| Depreciation and amortization: | ---- | -89.27%40.99M | ---- | 2.28%382.02M | ---- | 2.43%373.52M | ---- | 9.83%364.66M | ---- | 18.13%332.02M |
| -Other depreciation and amortization | ---- | -0.30%-1.98M | ---- | 29.23%-1.98M | ---- | 3.16%-2.79M | ---- | -61.15%-2.88M | ---- | -41.76%-1.79M |
| Financial expense | ---- | -24.58%87.65M | ---- | 53.34%116.22M | ---- | 22.78%75.79M | ---- | -18.45%61.73M | ---- | -16.64%75.7M |
| Unrealized exchange loss (gain) | ---- | -153.41%-10.71M | ---- | 90.44%-4.23M | ---- | -157.36%-44.2M | ---- | -165.92%-17.17M | ---- | 322.98%26.05M |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---3.9M | ---- | ---- |
| Adjustment items | ---- | -0.30%-1.98M | ---- | 29.23%-1.98M | ---- | 3.16%-2.79M | ---- | -61.15%-2.88M | ---- | -41.76%-1.79M |
| Operating profit before the change of operating capital | ---- | -8.29%799.25M | ---- | 18.01%871.52M | ---- | -16.10%738.51M | ---- | 18.60%880.24M | ---- | 8.15%742.22M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -16.07%92.33M | ---- | -49.89%110.01M | ---- | 141.18%219.55M | ---- | -434.81%-533.08M | ---- | 174.13%159.22M |
| Accounts receivable (increase)decrease | ---- | -251.24%-232.95M | ---- | -136.17%-66.32M | ---- | 293.36%183.35M | ---- | -75.44%-94.82M | ---- | -9.28%-54.05M |
| Accounts payable increase (decrease) | ---- | 11.74%132.41M | ---- | 139.76%118.51M | ---- | -205.25%-298.03M | ---- | 765.80%283.16M | ---- | -184.10%-42.53M |
| Special items for working capital changes | ---- | 289.04%14.04M | ---- | -367.66%-7.43M | ---- | 15.54%2.77M | ---- | 137.04%2.4M | ---- | 52.91%-6.48M |
| Cash from business operations | ---- | -21.55%805.08M | ---- | 21.29%1.03B | ---- | 57.31%846.15M | ---- | -32.63%537.89M | ---- | 74.00%798.38M |
| Other taxs | ---- | -67.43%-44.52M | ---- | 63.37%-26.59M | ---- | -377.03%-72.59M | ---- | 65.54%-15.22M | ---- | 13.57%-44.16M |
| Special items of business | 14.23%348.23M | ---- | -21.01%304.84M | ---- | 40.45%385.94M | ---- | 7.37%274.79M | ---- | -10.95%255.94M | ---- |
| Net cash from operations | 14.23%348.23M | -23.92%760.56M | -21.01%304.84M | 29.23%999.7M | 40.45%385.94M | 48.00%773.56M | 7.37%274.79M | -30.70%522.67M | -10.95%255.94M | 84.97%754.22M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -18.97%5.04M | -23.37%12.52M | -28.60%6.22M | -1.40%16.34M | 82.19%8.71M | -19.20%16.57M | -54.49%4.78M | 148.26%20.51M | 155.36%10.5M | 18.66%8.26M |
| Dividend received - investment | ---- | ---- | ---- | --3.44M | ---- | ---- | ---- | --906K | ---- | ---- |
| Loan receivable (increase) decrease | ---- | 28.68%-2.55M | ---- | -669.32%-3.58M | ---- | -80.64%629K | ---- | --3.25M | ---- | ---- |
| Decrease in deposits (increase) | 190.40%36.8M | -211.10%-17.91M | -68.93%12.67M | -90.08%16.12M | 637.51%40.79M | 183.11%162.45M | -261.62%-7.59M | -2,635.92%-195.47M | -92.99%4.7M | 321.88%7.71M |
| Sale of fixed assets | -90.77%935K | 271.67%16.42M | 5.55%10.13M | -53.95%4.42M | 146.46%9.6M | 32.30%9.6M | 190.38%3.89M | 58.73%7.25M | 12.97%1.34M | -84.01%4.57M |
| Purchase of fixed assets | 20.99%-118.03M | -17.32%-323.08M | -26.24%-149.38M | 24.76%-275.39M | 40.82%-118.33M | -62.96%-366.01M | -128.76%-199.95M | 6.11%-224.6M | -11.41%-87.41M | 53.54%-239.23M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 87.88%-7.37M |
| Cash on investment | ---- | ---22.32M | ---- | ---- | ---- | ---- | ---- | ---27.6M | ---27.6M | ---- |
| Other items in the investment business | ---- | --1.29M | ---- | ---- | ---- | 71.83%2.53M | ---- | -88.98%1.47M | --1.47M | -33.37%13.37M |
| Net cash from investment operations | 37.47%-75.26M | -40.63%-335.62M | -103.17%-120.36M | -36.98%-238.66M | 70.21%-59.24M | 57.94%-174.23M | -105.01%-198.86M | -94.78%-414.28M | -617.36%-97M | 58.52%-212.68M |
| Net cash before financing | 47.97%272.97M | -44.16%424.94M | -43.53%184.48M | 26.98%761.04M | 330.26%326.69M | 452.90%599.33M | -52.23%75.93M | -79.98%108.4M | -41.97%158.94M | 616.04%541.54M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 0.91%1.05B | 57.21%2.44B | 63.17%1.04B | -4.08%1.55B | -82.77%635.85M | -54.75%1.62B | 166.67%3.69B | 15.79%3.58B | -29.92%1.38B | 22.83%3.09B |
| Refund | 17.84%-1.09B | -11.57%-2.39B | -33.93%-1.33B | -26.68%-2.14B | 73.30%-990.58M | 54.39%-1.69B | -172.21%-3.71B | -23.94%-3.71B | 29.83%-1.36B | -40.84%-2.99B |
| Interest paid - financing | 5.79%-40.93M | 27.92%-92.16M | 26.50%-43.45M | -40.69%-127.86M | -92.46%-59.11M | -37.24%-90.88M | -37.88%-30.71M | 18.26%-66.22M | 41.04%-22.28M | 18.67%-81.01M |
| Dividends paid - financing | ---- | -159.56%-256.94M | ---- | 50.10%-98.99M | ---- | -28.05%-198.4M | ---- | -156.90%-154.93M | ---- | 13.43%-60.31M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | 196.64%22.68M | --21.79M | -20.00%7.64M | ---- | --9.56M |
| Net cash from financing operations | 67.19%-114.93M | 59.13%-356.38M | 19.37%-350.27M | -130.97%-872.03M | -958.90%-434.41M | -3.75%-377.55M | -201.74%-41.03M | -660.68%-363.91M | 53.46%-13.6M | -122.75%-47.84M |
| Effect of rate | 318.37%11.43M | -30.65%-16.12M | 77.36%-5.23M | 82.24%-12.34M | 19.67%-23.11M | -212.95%-69.49M | -362.05%-28.77M | 12.66%61.52M | 281.89%10.98M | 761.03%54.61M |
| Net Cash | 195.32%158.04M | 161.77%68.56M | -53.91%-165.79M | -150.04%-110.99M | -408.62%-107.72M | 186.80%221.79M | -75.98%34.9M | -151.75%-255.51M | -40.59%145.34M | 368.85%493.7M |
| Begining period cash | 5.65%980.28M | -11.73%927.84M | -11.73%927.84M | 16.94%1.05B | 20.86%1.05B | -17.75%898.87M | -20.41%869.76M | 100.69%1.09B | 100.69%1.09B | 21.68%544.55M |
| Cash at the end | 51.92%1.15B | 5.65%980.28M | -17.77%756.81M | -11.73%927.84M | 5.07%920.34M | 16.94%1.05B | -29.88%875.89M | -17.75%898.87M | 59.50%1.25B | 100.69%1.09B |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.